BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
May 6, 2026
Company
DiaMedica Therapeutics Inc. (DMAC)
Other upcoming events for DMAC
Phase 3 Readout
Phase 3 Topline: Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety a
Dec 1, 2026
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
DMAC Overview
PDUFA Dates
Phase 3 Readouts